VCEL — VERICEL CORP ORD (Healthcare >> Biotechnology)
VCEL FAQ
What is VCEL's P/E ratio?
VERICEL CORP ORD (VCEL) currently trades at a P/E ratio of 62.13.
What is VCEL's ROE?
VERICEL CORP ORD reports a Return on Equity (ROE) of 6.02%.
What is VCEL's dividend yield?
VERICEL CORP ORD offers a dividend yield of 0.00%.
What is VCEL's Deepscope Quality Score?
Deepscope rates VCEL's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VCEL?
Deepscope's AI Timing Score for VCEL is 29 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VCEL belong to?
VERICEL CORP ORD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 34.74
Price
0.29
(0.84%)
Day Change
|
|
|---|
VCEL, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
2684
|
| Magic Formula Rank by ROE |
2684
|
| Magic Formula Rank by ROIC |
2732
|
| Price | 34.74 |
| PBV / Sector |
4.94 / 4.48
|
| Earning Per Share | 0.42 |
| PE / Sector |
62.13 / 16.68
|
| PEG or PE/Growth / Sector |
-0.44 / 0.53
|
| Average 1M Daily Value |
21.38 M
GREAT
|
| Average 1W Daily Value |
19.23 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:06 |
| Symbol | VCEL |
| Name | VERICEL CORP ORD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 51.07 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,759.30 / 8,483.11 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 64 Sidney Street, Cambridge, MA, United States, 02139
Phone: 617 588 5555
Website: https://www.vcel.com
Employees: 398
Sector: Healthcare >> Biotechnology
Description: Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google